advertisement
Abstract #13495 Published in IGR 8-1
24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma
Konstas AG; Mikropoulos D; Kaltsos K; Jenkins JN; Stewart WCOphthalmology 2006; 113: 446-450
PURPOSE: To evaluate the quality of 24-hour intraocular pressure (IOP) control between morning- and evening-dosed travoprost in primary open-angle glaucoma patients. DESIGN: Prospective, crossover, double-masked comparison. METHODS: After a 6-week medicine-free period, 33 patients were randomized to receive travoprost dosed in the morning or evening. After 8 weeks of treatment, a 24-hour IOP curve was performed at 6 am, 10 am, 2 pm, 6 pm, 10 pm, and 2 am. Patients were then treated with the opposite dosing regimen for another 8 weeks, after which the 24-hour IOP curve was repeated. MAIN OUTCOME MEASURES: Twenty-four-hour IOP. RESULTS: The untreated mean 24-hour IOP was 23.6 ± 2.0 mmHg. There were no differences for mean 24-hour IOP between the morning (17.5 ± 1.9 mmHg) and evening (17.3 ± 1.9 mmHg) dosings (P = 0.7). At 10 am, the evening dosing provided a statistically lower IOP (17.2 ± 2.1 mmHg) than the morning dosing (19.1 ± 2.5 mmHg) (P = 0.02). Evening dosing demonstrated a statistically lower 24-hour fluctuation of IOP (3.2 ± 1.0 mmHg) than morning dosing (4.0 ± 1.5 mmHg) (P = 0.01). Safety was similar, with conjunctival hyperemia being the most common adverse event (n = 9 [27% for morning dosing] and n = 11 [33% for evening dosing], P = 0.6). CONCLUSIONS: This study suggests that both morning and evening dosings of travoprost provide effective 24-hour IOP reduction. However, the evening dosing of travoprost demonstrates slightly greater daytime efficacy, with a narrower range of 24-hour pressure.
Dr. A.G. Konstas, Glaucoma Unit, Department of Ophthalmology, A University, AHEPA Hospital, Thessaloniki, Greece
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
